Skip to main content

Table 2 Clinical and other characteristics of hypertensive patients

From: Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia

Variables   Total = 238 (%) MetS p-value
Yes = 116 (%) No = 122 (%)
Duration since the diagnosis of HTN ≤5 year 152 (63.9) 73 (62.9) 79 (64.8)  
6–10 year 53 (22.3) 21 (18.1) 32 (26.2)  
≥11 year 33 (13.9) 22 (19.0) 11 (9.0) 0.049
Duration since starting anti-hypertensive agents: No 12 (5.0) 7 (6.0) 5 (4.1)  
≤5 year 157 (66.0) 75 (64.7) 82 (67.2)  
6–10 year 47 (19.7) 18 (15.5) 29 (23.8)  
≥11 year 22 (9.2) 16 (13.8) 6 (4.9) 0.055
Family history of chronic diseases: No 188 (79.0) 84 (72.4) 104 (85.2)  
Diabetes 18 (7.6) 12 (10.3) 6 (4.9)  
HTN 32 (13.4) 20 (17.2) 12 (9.8) 0.05
HTN drugs combination Not started 12 (5.0) 7 (6.0) 5 (4.1)  
Single 72 (30.3) 27 (23.3) 45 (36.9)  
Two 129 (54.2) 69 (59.5) 60 (49.2)  
Three 25 (10.5) 13 (11.2) 12 (9.8) 0.14
Mean BMI, Kg/m2, (±SD)   25.1 (5.0) 27.3 (4.3) 23.6 (4.3) <0.0001
 Underweight (<18.5 Kg/m2) 15 (6.3) 4 (3.4) 11 (9.0)  
 Normal (18.5–24.9Kg/m2) 99 (41.6) 30 (25.9) 69 (56.6)  
 Overweight (25–29.9 Kg/m2) 83 (34.9) 49 (42.2) 34 (27.9)  
 Obese (>30 Kg/m2) 41 (17.2) 33 (28.4) 8 (6.6) <0.0001 a
Mean WC, cm (±SD)   89.7 (11.9) 95.4 (11.6) 84.5 (9.8) 0.002
Mean SBP, mmHg (±SD)   134 (18.1) 138.7 (16.3) 131.3 (19.1) <0.0001
Mean DBP, mmHg (±SD)   84.9 (12.4) 87.9 (11) 82 (12.6) <0.0001
Mean FBS, mg/dl (±SD)   125.3 (50.3) 142.9 (56.9) 108.6 (36.1) <0.0001
Mean HDL-c, mg/dl (±SD)   43.6 (15.2) 39.4 (14.5) 47.6 (14.9) <0.0001
Mean TGs, mg/dl (±SD)   207 (121) 261 (141) 157 (65.4) <0.0001
  1. BMI body mass index, DBP diastolic blood pressure, FBS fasting blood sugar, HTN hypertension, HDL-c high density lipoprotein cholesterol, SD standard deviation, WC waist circumference, SBP systolic blood pressure, TGs triglycerides; asignificance by fisher’s exact test